Related Experiment Video
Updated: May 16, 2026
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management
Ashley R Branham1, Aaron J Katz, Joseph S Moose
1Moose Pharmacy, Concord, NC 28025, USA. ashley@moosepharmacy.com
Objective:
To compare the estimated cost avoidance (ECA) of pharmacist-provided medication therapy management (MTM) services among common disease states encountered in community pharmacy practice.
Design:
Retrospective analysis.
Setting:
Nine community pharmacies in North Carolina.
Patients:
Three hundred and sixty-four patients who are 65 years of age or older, a Medicare Part D beneficiary and a North Carolina resident.
Interventions:
An MTM pharmacist-provider conducted medication reviews to eligible patients between July 2009 and October 2009. For each encounter, patient interventions, pharmacist recommendations, and ECA were recorded.
Main Outcome Measure:
ECA.
Results:
In 9 pharmacy locations, 634 MTM interventions were documented during the study period. The ECA in a 4-month period yielded approximately $494 000. Comprehensive medication reviews, new prescription counseling and appropriate medication administration, and technique counseling made up nearly two-thirds of interventions. Overall, the probability that an MTM intervention would result in an ECA greater than $0 was .35.
Conclusions:
Pharmacist-provided MTM effectively reduced costs associated with patient medication use. Such interventions reduced costs in overall health care specifically in the areas of cardiovascular, gastroesophageal reflux disease, pulmonary, and diabetes groups.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:16Therapeutic Drug Monitoring: Overview and Classification